October 23, 2019

New Content Will Provide Clinical Insights and Actionable Tips
to Assist Eye Care Professionals and Their Practices

ORLANDO, October 23, 2019—Eye care professionals attending Academy 2019 have access to hundreds of scientific papers and posters that showcase the latest advances in optometry research. But digesting and translating this information for the benefit of their own practices can be a challenge. To further support its clinical education initiatives, CooperVision plans to publish a series of summaries of research presented in Orlando on ECP Viewpoints, its blog for eye care professionals.

Articles will be authored with the practicing ECP in mind, distilling and translating data for application in the exam lane to benefit the professional and patient alike. Topics include contact lens performance and design, materials science, patient wearing experience, and more.

“Conferences like Academy offer a wealth of information, yet the reality is that there’s too much for any one attendee to fully see and absorb. This initiative is designed for practitioners who want to grow their knowledge and ultimately, the level of care they can provide their patients,” said Jennifer Palombi, OD, FAAO, Senior Manager, Professional and Scientific Communication, North America, CooperVision.

“After multiple days of being immersed in research, returning to your practice to implement what you learned can be overwhelming. Where and how do you start? This CooperVision ECP Viewpoints series will break down key research and offer easily digestible summaries and actionable tips for patient care and practice management.”

The series will also serve as a resource for ECPs unable to attend Academy 2019 but who are interested in experiencing some of what was shared with their peers.

The Academy 2019 research series will be published in the weeks following the conference. To read or subscribe to ECP Viewpoints℠, visit www.coopervision.com/practitioner/ecp-viewpoints.


# # #


About CooperVision
CooperVision, a unit of CooperCompanies (NYSE: COO), is one of the world’s leading manufacturers of soft contact lenses. The Company produces a full array of monthly, two-week and daily disposable contact lenses, all featuring advanced materials and optics. CooperVision has a strong heritage of solving the toughest vision challenges such as astigmatism and presbyopia; and offers the most complete collection of spherical, toric and multifocal products available. Through a combination of innovative products and focused practitioner support, the company brings a refreshing perspective to the marketplace, creating real advantages for customers and wearers. For more information, visit www.coopervision.com.

About CooperCompanies
CooperCompanies (“Cooper”) is a global medical device company public traded on NYSE (NYSE: COO). Cooper operates through two business units, CooperVision and CooperSurgical. CooperVision brings a refreshing perspective on vision care with a commitment to developing a wide range of high-quality products for contact lens wearers and providing focused practitioner support. CooperSurgical is committed to advancing the health of women, babies and families with its diversified portfolio of products and services focusing on medical devices and fertility & genomics. Headquartered in San Ramon, Calif., Cooper has a workforce of more than 12,000 employees with products sold in over 100 countries. For more information, please visit www.coopercos.com.

Media Contact
Heather Kowalczyk
McDougall Communications for CooperVision, Inc.
heather@mcdougallpr.com or +1-585-434-2148